These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32297641)

  • 1. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
    Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of non-schistosomal colorectal cancer and schistosomal colorectal cancer.
    Wang W; Lu K; Wang L; Jing H; Pan W; Huang S; Xu Y; Bu D; Cheng M; Liu J; Liu J; Shen W; Zhang Y; Yao J; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):149. PubMed ID: 32611359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
    Kwak Y; Yun S; Nam SK; Seo AN; Lee KS; Shin E; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    J Transl Med; 2017 Aug; 15(1):167. PubMed ID: 28764718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of c-MYC Amplification in Esophageal Squamous Cell Carcinoma.
    Huang J; Jiang D; Zhu T; Wang Y; Wang H; Wang Q; Tan L; Zhu H; Yao J; Hou Y
    Ann Thorac Surg; 2019 Feb; 107(2):436-443. PubMed ID: 30273571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin.
    Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS
    BMC Cancer; 2016 Sep; 16(1):730. PubMed ID: 27619912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.
    Park K; Kwak K; Kim J; Lim S; Han S
    Hum Pathol; 2005 Jun; 36(6):634-9. PubMed ID: 16021569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray.
    Xie D; Sham JS; Zeng WF; Lin HL; Che LH; Wu HX; Wen JM; Fang Y; Hu L; Guan XY
    Int J Cancer; 2003 Dec; 107(6):896-902. PubMed ID: 14601048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
    Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
    Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt.
    Zalata KR; Nasif WA; Ming SC; Lotfy M; Nada NA; El-Hak NG; Leech SH
    Cell Oncol; 2005; 27(4):245-53. PubMed ID: 16308474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency.
    Ren J; Jin F; Yu Z; Zhao L; Wang L; Bai X; Zhao H; Yao W; Mi X; Wang E; Olopade OI; Wei M
    Tumour Biol; 2013 Dec; 34(6):3945-58. PubMed ID: 23860775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients.
    Khaleghian M; Shakoori A; Razavi AE; Azimi C
    Asian Pac J Cancer Prev; 2015; 16(16):7061-9. PubMed ID: 26514491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
    Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
    Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
    Wang W; Deng J; Wang Q; Yao Q; Chen W; Tan Y; Ge Z; Zhou J; Zhou Y
    Oncol Rep; 2017 Jul; 38(1):245-252. PubMed ID: 28560438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S
    Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
    Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
    Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
    Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
    Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.